---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-019893"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2025-07-16T23:59:59+00:00"
generated_at: "2026-05-18T06:18:36.778655+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Indaptus Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq notice on July 14, 2025 that closing bid price was ≥$1.00 for 10 consecutive business days (June 27-July 11, 2025).
- Previously reported non-compliance on January 31, 2025; had until July 30, 2025 to regain compliance.
- Nasdaq considers the bid price deficiency matter now closed.
- Regaining compliance removes imminent delisting risk from The Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001641172-25-019893
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2025-07-16T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000164117225019893/0001641172-25-019893-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000164117225019893/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-019893
- JSON: https://secwatch.observer/filing/0001641172-25-019893.json
- Plain text: https://secwatch.observer/filing/0001641172-25-019893.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.